Detection of Systemic Diseases Such as Hepatobiliary Diseases From Ocular Images Via Deep Learning

Oculomics is an emerging interdisciplinary field that deciphers multi-dimensional, high-throughput ocular data to predict, diagnose, and monitor systemic diseases and health span.In recent years, artificial Intelligence may provide insight into exploring the potential covert association behind and reveal some early ocular architecture changes in individuals with systemic diseases. The investigators conducted a survey to explore the association between the eye and systemic diseases via deep learning, to develop and evaluate different deep learning models to predict the systemic diseases such as hepatobiliary disease by using ocular images.

Study Overview

Study Type

Observational

Enrollment (Actual)

775

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Guangdong
      • Guangzhou, Guangdong, China, 510000
        • Zhongshan Ophthalmic Center, Sun Yat-sen Univerisity

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

ocular images collected from the Third Affiliated Hospital of Sun Yat-sen University and Pazhou Medical Centre of Aikang Health Care

Description

Inclusion Criteria:

  • The quality of ocular images should clinical acceptable.
  • Complete clinical information such as baseline demographic characteristics, the history of systematic diseases and so on.

Exclusion Criteria:

  • Individuals diagnosed with severe eye diseases or acute systematic diseases.
  • Incompatible with ocular examinations.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
development dataset 01
ocular images collected from the Third Affiliated Hospital of Sun Yat-sen University
The training dataset was used to train the deep learning model, which was validated and tested by the other two datasets.
development dataset 02
ocular images collected from Pazhou Medical Centre of Aikang Health Care
The training dataset was used to train the deep learning model, which was validated and tested by the other two datasets.
test dataset 01
ocular images collected from the Third Affiliated Hospital of Sun Yat-sen University
The training dataset was used to train the deep learning model, which was validated and tested by the other two datasets.
test dataset 02
ocular images collected from Pazhou Medical Centre of Aikang Health Care
The training dataset was used to train the deep learning model, which was validated and tested by the other two datasets.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
area under the receiver operating characteristic curve of the deep learning system
Time Frame: baseline
The investigators will calculate the area under the receiver operating characteristic curve of deep learning system and compare this index between deep learning system and human doctors
baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
sensitivity of the deep learning system
Time Frame: baseline
The investigators will calculate the sensitivity of deep learning system and compare this index between deep learning system and human doctors
baseline
specificity of the deep learning system
Time Frame: baseline
The investigators will calculate the specifity of deep learning system and compare this index between deep learning system and human doctors
baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 10, 2020

Primary Completion (Actual)

July 30, 2024

Study Completion (Actual)

July 30, 2024

Study Registration Dates

First Submitted

May 6, 2026

First Submitted That Met QC Criteria

May 6, 2026

First Posted (Actual)

May 12, 2026

Study Record Updates

Last Update Posted (Actual)

May 14, 2026

Last Update Submitted That Met QC Criteria

May 11, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2019KYPJ163

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Systemic Diseases

Subscribe